Broad-spectrum β-lactams in obese non-critically ill patients


Objectives:Obesity may alter the pharmacokinetics of β-lactams. The goal of this study was to evaluate if and why serum concentrations are inadequate when standard β-lactam regimens are administered to obese, non-critically ill patients.Subjects and methods:During first year, we consecutively included infected, obese patients (body mass index (BMI) ⩾30 kg m… (More)
DOI: 10.1038/nutd.2014.15


4 Figures and Tables